BERNENGO, M.; VANACLOCHA, F.; DUVIC, M.; KUZEL, T.; KERDEL, F.; PINTER-BROWN, L.; BOSLY, A.; OKADA, C.; BRENEMAN, D.; ZINZANI, P.; BECKER, J.; HUGHEY, L.; ARDAIZ, M.; ZAIN, J.; ZHANG, L. A Phase II international, multicenter study of oral panobinostat (LBH589) in patients with refractory cutaneous T-cell lymphoma. Hematology Meeting Reports (formerly Haematologica Reports), [S. l.], v. 2, n. 5, 2009. DOI: 10.4081/hmr.v2i5.725. Disponível em: https://www.pagepress.org/journals/hmr/article/view/725. Acesso em: 3 jul. 2024.